Arena Pharmaceuticals Appoints Jennifer Jarrett to Board of Directors

Arena Pharmaceuticals announced the appointment of Jennifer Jarrett to the Company’s Board of Directors.  Ms. Jarrett has over 20 years of experience as a senior executive and finance professional in the life sciences industry.

“We are excited to have someone with Jennifer’s financial, business and strategic experience joining our board at such an important time,” said Tina Nova, Chairman of the Board of Directors of Arena. “We are confident that her vast industry insights and business development, operational and financial expertise will be highly beneficial to Arena as we continue to advance our promising pipeline and plan for key clinical milestones in 2017.”

Ms. Jarrett currently serves as Chief Business Officer and Chief Financial Officer of Arcus Biosciences, a biotechnology company developing next generation cancer immunotherapies. Prior to Arcus, she was Chief Financial Officer of Medivation, which was acquired by Pfizer in 2016. Before Medivation, Ms. Jarrett spent 20 years in investment banking, most recently at Citigroup, where she ran the firm’s west coast life sciences investment banking practice, and prior to that at Credit Suisse and Donaldson, Lufkin & Jenrette. In 2014, she was named one of the Most Influential Women in Bay Area Business by the San Francisco Business Times. Ms. Jarrett received a Bachelor of Arts in economics from Dartmouth College and an MBA from Stanford Graduate School of Business.